Probiotic may reduce the risk of common cold: Yakult study
By Stephen Daniells+, 07Feb2017
Related topics: Probiotics and prebiotics, Immune support, Respiratory health, Research, Supplements, Dairy.
Daily consumption of a fermented milk product with Lactobacillus casei strain Shirota may reduce the risk of upper respiratory tract infections (URTIs) in healthy middleaged office workers, says a new study. Scientists from the Yakult Central Institute reported that, after 12 weeks, the incidence of the URTIs in the probiotic group was more than half the rate observed in the control group.Writing in the current issue of the European Journal of Nutrition the scientists noted that probiotic consumption was associated with improvements in both immunological parameters and stress markers.“The present study demonstrated the efficacy of prob iotics in typical desk workers,” they wrote. “In general, such employees work under pressure and stress every day, which might b e a risk factor for lowered immune defenses. Daily consumption of certain prob iotics at higher doses may prevent disturb ances in immune function resulting from stressful events in daily life. “Thus, these results suggested the potential use of prob iotics to improve health in the workplace.” The cost savings could be significant, with data from the US Centers for Disease Control and Prevention indicating that 22 million school days and 20 million workdays in adults are lost annually due to the common cold in the USA. In addition, the economic impact of colds in the US is estimated to be about $40 billion every year.
The Japanese researchers recruited 96 male office workers aged between 30 and 49 to participate in their randomized controlled trial. During winter, the men were randomly assigned to receive fermented milk with probiotics (L. casei strain Shirota at a daily dose of 100 billion viable cells) or a control milk for 12 weeks. Results showed that the incidence of URTIs during the 12week intervention period was 22% in the probiotic group, compared to 53% in the control group. In addition, the incidence of the common cold in the probiotic group was 18% versus 45% in the control group. Men in the probiotic group also had a significantly higher URTIfree rate than men in the control group, said the Yakult scientists. “The cumulative numb er of URTI episodes and cumulative days with URTI symptoms per person was lower in the [probiotic] group, and the duration per episode was shorter,” they added. The probiotics may work by modulating the immune system as well as a potential effect on the stress marker cortisol. The data indicated that, after six weeks of control milk consumption, the activity of NK cells decrease, while salivary levels of cortisol increased, but these changes did not occur in the probiotic group. “NK cells play a very important role in the prevention of viral infections, including URTIs,” explained the scientists. “Future studies should focus on nervous systemrelated actions of prob iotics as well as their direct immune modulatory activities to ob tain a b etter understanding of the precise mechanisms of preventing viral infections via prob iotics,” they wrote.
Source: European Journal of Nutrition
February 2017, Volume 56, Issue 1, pp 45–53, doi: 10.1007/s0039401510561
“Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper
respiratory tract infections in healthy middleaged
Authors: K. Shida et al.